moxisylyte has been researched along with Airway Hyper-Responsiveness in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nobata, K | 1 |
| Fujimura, M | 1 |
| Ishiura, Y | 1 |
| Hirose, T | 1 |
| Furusyou, S | 1 |
| Myou, S | 1 |
| Kurashima, K | 1 |
| Kasahara, K | 1 |
| Nakao, S | 1 |
1 other study available for moxisylyte and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Alpha(1L)-, but not alpha(1H)-, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Bron | 2002 |